The 2026 Scientific Frontiers in Genomic Stability Shenzhen Symposium was successfully held on April 7–8, 2026, at the Lihu Campus of Shenzhen University. The symposium was co-organized by the Shenzhen University Medical School and the Shenzhen Society for Cell Biology. The event brought together leading researchers to present and discuss the latest findings in genomic instability and disease, the tumor microenvironment, DNA repair mechanisms, and the regulation of DNA replication. More than 80 participants attended, including over ten distinguished experts from Japan and South Korea, as well as international doctoral students from the Medical School.

 Professor Xingzhi Xu delivers the welcome address.

On the morning of April 8, Professor Xingzhi Xu, Executive Dean of Shenzhen University Medical School, officially opened the symposium and delivered a welcome address on behalf of the Medical School. Professor Hiroshi Harada, Director of the Radiation Biology Center at Kyoto University, Japan, and Professor Shunichi Takeda, Distinguished Professor at Shenzhen University Medical School, gave keynote presentations. Professor Harada spoke on "Radiation Medicine: Challenges and Opportunities from Bench to Bedside – Insights from Tumor Hypoxia and Genome Instability," while Professor Takeda presented on "MRE11 is essential for homology-directed repair beyond DNA end resection."

Professor Hiroshi Harada (left) and Professor Shunichi Takeda (right) deliver their keynote addresses.

During the subsequent symposium sessions, more than ten early-career researchers and students from China, Japan, and South Korea shared their latest research progress. These included Seula Jeong (Institute for Basic Science, South Korea), Juyeong Yoo (Ulsan National Institute of Science and Technology, South Korea), Takakuni Dohkai (Kyoto University, Japan), and Xiaoxuan Zhu (National Institute of Genetics, Japan), among others.

Academic presentations and exchanges.

The 2026 Scientific Frontiers in Genomic Stability Shenzhen Symposium brought together top scientists from multiple countries. Through high-level academic exchanges, the symposium promoted breakthroughs in original research, facilitated knowledge sharing and technological innovation, and contributed to the development of comprehensive strategies for the prevention, diagnosis, and treatment of diseases associated with genomic instability. The event served as an effective platform for collaboration between scientists and clinical experts, accelerating the translation of basic research findings into clinical applications. It also made a positive contribution to advancing the diagnosis and treatment of cancer- and aging-related diseases in Asia and beyond, while enhancing the international visibility of Shenzhen University.

Group photo of the symposium participants.